Literature DB >> 1901378

Mutated interleukin-5 monomers are biologically inactive.

A N McKenzie1, B Ely, C J Sanderson.   

Abstract

Interleukin-5 contains only two cysteine residues both of which appear to be involved in the dimerisation of the molecule to form a disulphide-linked homodimer (Minamitake et al., J. Biochem. 107, 292-297, 1990). However, it remains unclear whether this linkage is necessary for the bioactivity of this cytokine. Site-directed mutagenesis was used to produce amino acid substitutions of either or both of the cysteines. The mutant proteins were all biologically inactive monomers, however when the two single mutant constructs were co-transfected, biologically active IL5 was produced. This is consistent with the dimer forming in a head-to-tail configuration.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1901378     DOI: 10.1016/0161-5890(91)90099-6

Source DB:  PubMed          Journal:  Mol Immunol        ISSN: 0161-5890            Impact factor:   4.407


  9 in total

1.  The RgpA-Kgp proteinase-adhesin complexes of Porphyromonas gingivalis Inactivate the Th2 cytokines interleukin-4 and interleukin-5.

Authors:  Vivian Tam; Neil M O'Brien-Simpson; Yu-Yen Chen; Colin J Sanderson; Beverley Kinnear; Eric C Reynolds
Journal:  Infect Immun       Date:  2009-01-21       Impact factor: 3.441

2.  The carboxy-terminal region of human interleukin-5 is essential for maintenance of tertiary structure but not for dimerization.

Authors:  A E Proudfoot; S C Brown; P Graber; F Talabot; C Y Arod; M C Peitsch; M Banks; M McKinnon; R Solari; T N Wells
Journal:  J Protein Chem       Date:  1996-07

3.  Engineering of a functional interleukin-5 monomer: a paradigm for redesigning helical bundle cytokines with therapeutic potential in allergy and asthma.

Authors:  R R Dickason; J D English; D P Huston
Journal:  J Mol Med (Berl)       Date:  1996-09       Impact factor: 4.599

Review 4.  Eosinophils in the 1990s: new perspectives on their role in health and disease.

Authors:  A J Wardlaw
Journal:  Postgrad Med J       Date:  1994-08       Impact factor: 2.401

5.  Thiols decrease cytokine levels and down-regulate the expression of CD30 on human allergen-specific T helper (Th) 0 and Th2 cells.

Authors:  A Bengtsson ; M Lundberg; J Avila-Cariño; G Jacobsson; A Holmgren; A Scheynius
Journal:  Clin Exp Immunol       Date:  2001-03       Impact factor: 4.330

6.  Structure-function analysis of interleukin-5 utilizing mouse/human chimeric molecules.

Authors:  A N McKenzie; S C Barry; M Strath; C J Sanderson
Journal:  EMBO J       Date:  1991-05       Impact factor: 11.598

Review 7.  Th2 cytokines and asthma. The role of interleukin-5 in allergic eosinophilic disease.

Authors:  S Greenfeder; S P Umland; F M Cuss; R W Chapman; R W Egan
Journal:  Respir Res       Date:  2001-03-08

Review 8.  Pathogenesis of eosinophilic chronic rhinosinusitis.

Authors:  Said Ahmad Shah; Hajime Ishinaga; Kazuhiko Takeuchi
Journal:  J Inflamm (Lond)       Date:  2016-04-06       Impact factor: 4.981

9.  Tissue eosinophilia induced by recombinant human interleukin-5 in the hamster cheek pouch membrane.

Authors:  M Minnicozzi; W N Durán; D Kim; G J Gleich; J Wagner; R W Egan
Journal:  Mediators Inflamm       Date:  1995       Impact factor: 4.711

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.